Ministry | Jotup

KFSH&RC Announced as Strategic Partner for the Saudi American Healthcare Forum 2024

Retrieved on:

星期二, 四月 23, 2024

RC, Hospital, Medicine, Research, Innovation, KFSH, Business, Newsweek, Ministry

RIYADH, Saudi Arabia, April 23, 2024 (GLOBE NEWSWIRE) -- KFSH&RC participates as a strategic partner in the Saudi American Healthcare Forum, which will take place on April 25th under the patronage of the Ministry of Health in Riyadh. This forum aims to discuss the primary healthcare challenges facing the American and Arab populations and to support collaboration, innovation, and healthcare partnerships between the two nations.

Key Points:

RIYADH, Saudi Arabia, April 23, 2024 (GLOBE NEWSWIRE) -- KFSH&RC participates as a strategic partner in the Saudi American Healthcare Forum, which will take place on April 25th under the patronage of the Ministry of Health in Riyadh.
This forum aims to discuss the primary healthcare challenges facing the American and Arab populations and to support collaboration, innovation, and healthcare partnerships between the two nations.
The forum will focus on key topics that contribute to the development of healthcare, in addition to creating a platform for bilateral information exchange, exploring cooperation opportunities, and sharing best practices in global healthcare.
The Saudi American Healthcare Forum will feature a broad attendance, including top businessmen, academics, and industry experts from both countries, to enhance initiatives and solutions, and support the existing bilateral relations based on "Healthcare Diplomacy".

PaxMedica Responds to Emergency Request for IV Suramin and Commits to Provide Immediate Access to PAX-101

Retrieved on:

星期二, 四月 23, 2024

NDA, African trypanosomiasis, MOH, IBN, Trypanosoma brucei, Physician, Ministry, DSM-IV codes, Government, Trypanosomiasis

The request seeks emergency access to the Company’s recently completed registration batches of PAX-101 (IV suramin) to address the critical shortage of medications required to combat the life-threatening sleeping sickness, also known as Trypanosoma brucei rhodesiense, Human African trypanosomiasis (TBr HAT), crisis in the region.

Key Points:

The request seeks emergency access to the Company’s recently completed registration batches of PAX-101 (IV suramin) to address the critical shortage of medications required to combat the life-threatening sleeping sickness, also known as Trypanosoma brucei rhodesiense, Human African trypanosomiasis (TBr HAT), crisis in the region.
Howard Weisman, Chairman and CEO of PaxMedica, emphasized the Company's dedication to providing immediate assistance in light of the urgent situation, stating: "The emergency request from the Ministry of Health of Malawi underscores the critical need for IV suramin to combat the continued devastating impact of sleeping sickness in the region.
PaxMedica has worked diligently for many years to ensure access to this life-saving medication for those in need and today’s response to an urgent crisis strongly demonstrates our commitment to this mission."
The decision comes in the wake of PaxMedica's recent completion of three pivotal registration/validation batches of PAX-101 ( PaxMedica - A Promising Path in Autism ), as part of its ongoing development program.

Italy is the Second European Country to Issue Emergency Use Authorization for Vestaron Peptide-Based Bioinsecticide for Control of Tomato Leafminer

Retrieved on:

星期一, 四月 22, 2024

The Italian Ministry of Health granted emergency use authorization for SPEAR LEP, Vestaron’s peptide-based insecticide.

Key Points:

The Italian Ministry of Health granted emergency use authorization for SPEAR LEP, Vestaron’s peptide-based insecticide.
Available for growers in Italy to use on tomatoes from March 28 to July 25, SPEAR LEP is a biological product that targets lepidopteran pests such as tomato leafminer, navel orangeworm, European grapevine moth, codling moth, loopers, and caterpillars.
An emergency use authorization for SPEAR LEP was granted by the Greek Ministry of Agriculture for use on tomato crops in February 2024.
“Farmers in Italy and Greece will now have access to a much-needed new mode of action to help them continue producing the food our growing society requires.

FuelPositive Announces Strategic Focus on Manitoba, Expanding Network and New Partnerships

Retrieved on:

星期四, 四月 18, 2024

University, Agriculture, Keystone Association, EEStor, Climate, Communication, Research, Ecology, UAN, Potato, Carbon, Growth, Farmer, Entrepreneurship, AG, Family, Ministry, Soil

With a clear focus on expanding its network, FuelPositive is ready to establish new partnerships that resonate with its mission, values, and most importantly, the needs of the Company’s primary customers – farmers.

Key Points:

With a clear focus on expanding its network, FuelPositive is ready to establish new partnerships that resonate with its mission, values, and most importantly, the needs of the Company’s primary customers – farmers.
As part of this initiative, FuelPositive is thrilled to unveil upcoming partnerships that will bolster its presence and deepen its impact throughout Manitoba and beyond.
New Manitoba Farmer-Partner and FuelPositive Advisor: Chad Berry
FuelPositive is delighted to announce the appointment of its new Farmer-Advisor, Chad Berry.
FuelPositive is excited to announce a groundbreaking new initiative: expanding our creative team with the addition of talented photographers and graphic designers.

Atico Reports Consolidated Financial Results for 2023

Retrieved on:

星期二, 四月 16, 2024

VANCOUVER, British Columbia, April 16, 2024 (GLOBE NEWSWIRE) -- Atico Mining Corporation (the “Company” or “Atico”) (TSX.V: ATY | OTC: ATCMF) today announced its financial results for the year ended December 31, 2023, posting income from mining operations of $7.4 million and a net loss of $5.8 million. Production for the year at Atico’s El Roble mine totaled 13.2 million pounds (“lbs”) of copper and 10,149 ounces (“oz”) of gold in concentrate at a cash cost(1) of $2.04 per payable pound of copper(2).

Key Points:

During the quarter, the Company generated sales of $17.3 million, where copper accounted for 89% and gold for 11%.
Atico Mining cordially invites all shareholders to its Annual General Meeting of Shareholders, at 10:00 am, Tuesday, June 18, 2024, at Suite 501 - 543 Granville Street, Vancouver, British Columbia.
Since obtaining control of the mine on November 22, 2013, Atico has upgraded the operation from a historical nominal capacity of 400 tonnes per day.
A focus in 2023 will be on increasing the resource and reserves estimate and extending the El Roble’s life of mine.

PaxMedica Receives Emergency Request for IV Suramin from African Health Ministry for Use in Treating Fatal Sleeping Sickness

Retrieved on:

星期二, 四月 16, 2024

TARRYTOWN, New York, April 16, 2024 (GLOBE NEWSWIRE) -- via IBN -- PaxMedica , Inc. (NASDAQ: PXMD ), a biopharmaceutical company focused on advancing treatments for neurological disorders, today announced it has received an urgent request from the Ministry of Health (MOH) of Malawi, asking for emergency access to IV suramin to avert a potential humanitarian crisis brought on by dwindling supplies of drugs used routinely to save lives in that region of Africa.

Key Points:

TARRYTOWN, New York, April 16, 2024 (GLOBE NEWSWIRE) -- via IBN -- PaxMedica , Inc. (NASDAQ: PXMD ), a biopharmaceutical company focused on advancing treatments for neurological disorders, today announced it has received an urgent request from the Ministry of Health (MOH) of Malawi, asking for emergency access to IV suramin to avert a potential humanitarian crisis brought on by dwindling supplies of drugs used routinely to save lives in that region of Africa.
PaxMedica, which just last week announced that it has completed execution of its three pivotal registration/validation batches of PAX-101 (an IV form of suramin), has brought this emergency request to the attention of the U.S. Food and Drug Administration (FDA) to determine potential impact, if any, on the ongoing development program and NDA submission plans for PAX-101.
PaxMedica has previously announced the completion of its recent Type B meeting with FDA in preparation for submitting an NDA for the use of PAX-101 in the treatment of the rare and fatal trypanosomal infection, Trypanosoma brucei rhodesiense, caused by the bite of a tsetse fly.
( PaxMedica - A Promising Path in Autism ) “Having the highest incidence of TBr HAT in the world, the Malawi Ministry of Health enabled PaxMedica to conduct the first and only analysis of efficacy in the actual setting where historically the vast majority of these infections have been successfully treated”, said Weisman.

Enlivex Announces Authorization from the Danish Regulatory Agency for the Company’s Randomized, Controlled Phase I/II Trial Evaluating Allocetra in Patients with Knee Osteoarthritis

Retrieved on:

星期二, 四月 16, 2024

Phase, Knee, Safety, Data monitoring committee, Osteoarthritis, Immunotherapy, Injection, Patient, Danish Medicines Agency, Ministry, Therapy, Danish, Pharmaceutical industry

As previously announced, the Company received its first regulatory approval for this trial from the Israeli Ministry of Health (IMOH) in January.

Key Points:

As previously announced, the Company received its first regulatory approval for this trial from the Israeli Ministry of Health (IMOH) in January.
The Phase I/II multi-center trial is composed of two stages.
In addition to evaluating safety, the blinded randomized stage is statistically-powered to assess the efficacy of Allocetra™ injections into the knee.
Oren Hershkovitz, Ph.D., CEO of Enlivex, commented “We are excited to push ahead with the clinical development of AllocetraTM in osteoarthritis.

Mangoceuticals Subsidiary, MangoRx Mexico, Executes Technical Agreement with Mexican Pharmaceutical Manufacturer for Initial Development and Production of its Mango Erectile Dysfunction (ED) Products

Retrieved on:

星期五, 四月 12, 2024

USD, Negotiation, Organization, Pharmacy, Production, Blister, Republic, Certification, OTC, Thought, Plant, Erectile dysfunction, Ministry, Marketing, Good, GMP, ED, Bioequivalence, Pharmaceutical industry

Dallas, Texas, April 12, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling a variety of men’s health and wellness products in the area of erectile dysfunction (ED), hair growth and hormone replacement therapies is excited to announce that its subsidiary, MangoRx Mexico S.A. de C.V. (“MangoRx Mexico”), has secured and executed a technical agreement with Emifarma S.A. de C.V (“Emifarma”) for the initial stages of development and testing (Bioequivalence and Accelerated Stability, required to obtain registry from COFEPRIS) of the Company’s Mango ED products intended for the Mexican and Latin American markets.

Key Points:

Founded in 1998 by a group of pharmaceutical professionals with experience in Development, Production and Quality, Emifarma is a Mexican company that employs more than 100 workers and has 4 plants that specialize in: Hormonal, Injectable, Additive and Oral Solid (tablet and powdered) products where they serve as a manufacturing partner for some of the most relevant pharmaceutical companies both domestically and internationally, operating in Mexico.
Emifarma is Certified for Good manufacturing Practices (GMP) by the following organizations: COFEPRIS, INVIMA, Ministry of Health of the Republic of Peru.
Specifically, COFEPRIS is recognized in the following additional countries: Columbia, Ecuador, El Salvador, Chile, Costa Rica and Panama.
Efi Karchmer, President of MangoRx Mexico stated, “after visiting, interviewing, and negotiating with many different pharmaceutical manufacturing companies over the past several months, we are very excited about our decision to partner with Emifarma in this endeavor.

AINN Layer2 Mainnet Launch: TVL Surpasses $600 Million on Day One

Retrieved on:

星期四, 四月 11, 2024

Ecosystem, Investment, TVL, Capital, AI, BTC, Web3, RATS, Ministry, Growth, Cryptocurrency

Jersey City, NJ, April 11, 2024 (GLOBE NEWSWIRE) -- AINN Layer2 Mainnet Launch: TVL Surpasses $600 Million on Day One

Key Points:

Jersey City, NJ, April 11, 2024 (GLOBE NEWSWIRE) -- AINN Layer2 Mainnet Launch: TVL Surpasses $600 Million on Day One
AINN Layer2, as the first Bitcoin Layer2 network focusing on Web3 + AI applications, has seen its total value locked (TVL) in assets staked surpass $600 million on its mainnet launch day, making it the Layer2 network with the largest TVL within 24 hours.
AINN Layer2 enables users to stake BRC-20 inscription assets like $BTC, $AINN, $ORDI, $SATS, and $RATS, among others, on the mainnet, with plans to support more types of assets for staking in the future.
Staking specified assets on the AINN Layer2 mainnet earns users TVL staking points, which can be exchanged for future $ANVM token airdrops.
AINN Layer2 focused on improving the fundamental elements of decentralized AI, creating a supportive environment for the growth of AI-based applications.

WEF Special Meeting Concludes in Riyadh With World Leaders Calling for Clear, Irreversible Path to Peace and Prosperity as Top Global Priority

Retrieved on:

星期一, 四月 29, 2024

The Special Meeting set the stage for the launch of several initiatives in the fields of healthcare, artificial intelligence, space and sustainability.

Key Points:

The Special Meeting set the stage for the launch of several initiatives in the fields of healthcare, artificial intelligence, space and sustainability.
It was one of several agreements signed by the Foundation with the Kingdom to improve global health systems and access.
The Center will serve as a platform for public-private dialogues and foster the growth of the global space economy.
A Saudi Arabia-led Sustainability Champions Network was also launched on the sidelines of the Special Meeting to accelerate Saudi’s private sector decarbonization efforts.